These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [New aspects in ANCA-associated vasculitides]. Lamprecht P Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181 [TBL] [Abstract][Full Text] [Related]
13. S1. Rituximab for ANCA-associated vasculitis: the experience in the United States. Clain JM; Specks U Presse Med; 2013 Apr; 42(4 Pt 2):530-2. PubMed ID: 23477713 [No Abstract] [Full Text] [Related]
14. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Booth AD; Jayne DR; Kharbanda RK; McEniery CM; Mackenzie IS; Brown J; Wilkinson IB Circulation; 2004 Apr; 109(14):1718-23. PubMed ID: 15037536 [TBL] [Abstract][Full Text] [Related]
15. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482 [TBL] [Abstract][Full Text] [Related]
16. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis. Mukhtyar C; Luqmani R Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383 [TBL] [Abstract][Full Text] [Related]
17. Targeting B lymphocytes as therapy for ANCA-associated vasculitis. Golbin JM; Specks U Rheum Dis Clin North Am; 2007 Nov; 33(4):741-54, v. PubMed ID: 18037114 [TBL] [Abstract][Full Text] [Related]
18. S3. Rituximab for ANCA-associated vasculitides: the French experience. Charles P; Guillevin L Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207 [No Abstract] [Full Text] [Related]